Sign inJoin waitlistJoin the waitlist

BF

Benjamin Fangman

Physician · Golden Valley Memorial Healthcare Hospital

Credentials: · · · · · · ·

History

Golden Valley Memorial Healthcare Hospital · American Oncology Network
2025–Present

University of Texas M D Anderson Cancer Center
2021–2024
Internal Medicine
University of Texas Southwestern Medical Center
2018–2021
University of Kansas School of Medicine
2014–2018

Research

Ral signaling pathway in health and cancer
Review · Cancer Medicine · 2017 · 42 citations
BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression
npj Breast Cancer · 2020 · 17 citations
Real-World Immune-Related Adverse Events in Patients With Early Triple-Negative Breast Cancer Who Received Pembrolizumab
JCO Oncology Practice · 2025 · 16 citations

AS
Aravind Sanjeevaiah
3 papers
Amy Jones
2 papers · 1 as a fellow
BR
Brandon Ricke
2 papers · 1 as a resident
Caleb Scheckel
2 papers · 2 as a fellow
Jesse Richards
2 papers · 2 as a resident
Kushal Shah
2 papers · 2 as a resident
KK
Kyle Kimura
2 papers · 1 as a resident
Nina Sanford
2 papers
Radhika Kainthla
2 papers
Shaalan Beg
2 papers
Suleyman Goksu
2 papers
Syed Kazmi
2 papers

Clinical trials

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Site PI · Recruiting · Phase 3
Takeda
2026–2033
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Site PI · Recruiting · Phase 3
Takeda
2025–2029
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Site PI · Recruiting · Phase 3
Takeda
2025–2032
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Site PI · Recruiting · Phase 3
Takeda
2025–2028